Daxor Receives Patents for Blood Volume Analyzer Kit in Canada and Japan.Business Editors/Health/Medical Writers NEW YORK--(BUSINESS WIRE)--May 7, 2004 Daxor Corporation, (AMEX AMEX See: American Stock Exchange : DXR), a leading medical instrumentation and biotechnology company, has been notified that it has received a patent in Canada and Japan for the Blood Volume Analyzer Volumex kit. At the present time the Company is not marketing in Canada and Japan, but will now begin to seek partners for marketing in those countries. With respect to Canada, the Company may elect to use its own representatives. The BVA-100 is the first semi-automated instrument approved by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for the measurement of human blood volume. It is used in conjunction with a single use kit, and has shortened the technician time required to perform a blood volume measurement to less than 1 hour from the 4 to 8 hours previously required. In addition to significantly reducing technician time, the measurement is accurate to within 98%. The system also provides for a significantly more precise predicted normal blood volume for each individual patient. Blood volume measurements have been available for over 60 years but were rarely utilized because of the difficulty in performing an accurate test as well as the time required for the test. The Company anticipates the filing of additional patents this year for the Blood Volume Analyzer which will enable the measurement of total body albumin in the human body. Albumin is a major protein in the circulatory system and is sometimes used as a substitute for red blood cell red blood cell: see blood. transfusions. Albumin derangements are common in heart disease, kidney disease, burn patients, and advanced stages of diabetes. The ability to know the total amount of albumin in the body would enable physicians to more accurately evaluate when albumin transfusions might be beneficial to a patient. Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. Among nationally renowned hospitals and other major medical institutions which have purchased the BVA-100 Blood Volume Analyzer are the Mayo Clinic, the Cleveland Clinic, NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. , and New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the Medical Center. Other conditions in which the blood volume analyzer has been used are congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. , syncope syncope Effect of temporary impairment of blood circulation to a part of the body. It is often used as a synonym for fainting, which is loss of consciousness due to inadequate blood flow to the brain. , and septic shock. More information about the BVA-100 and other Daxor products and services can be found at www.daxor.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion